Sagimet Biosciences
SGMT
SGMT
82 hedge funds and large institutions have $71.6M invested in Sagimet Biosciences in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+1
Holders Change %
+1.23%
% of All Funds
1.19%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
22
Reduced
21
Closed
21
Calls
$3K
Puts
$134K
Net Calls
-$131K
Net Calls Change
-$131K
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$4.09M |
| 2 |
2
Morgan Stanley
New York
|
$1.16M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$1.69M |
| 4 |
4
Goldman Sachs
New York
|
$896K |
| 5 |
5
Alyeska Investment Group
Chicago,
Illinois
|
$4.37M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$3.09M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$148K |
| 3 |
RI
3
RTW Investments
New York
|
$1.71M |
| 4 |
WP
4
Woodline Partners
San Francisco,
California
|
$0 |
| 5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$8.09M |
